 |
|
|
 |
Book Review Epidemiology of the Rheumatic Diseases, 2nd edition. ALAN J SILMAN, MD; MARC C. HOCHBERG, MD, EDITORS. Oxford University Press: New York, 2001, 382 pages, price $134.95 US The first edition of Epidemiology of the Rheumatic Diseases was a key reference for descriptive and risk factor data for a range of rheumatologic conditions. This revised edition promises to continue in this role. The book begins with an overview of population based approaches to the study of musculoskeletal epidemiology, followed by chapters on rheumatic conditions including inflammatory joint diseases, connective tissue disorders, degenerative and metabolic bone and joint diseases, and regional and widespread pain disorders. Review of morbidity and mortality statistics, and risk factor study results, is provided for each disease. New to this edition is the population studies overview and expanded scope of diseases represented. Each chapter provides a current and extensive review of descriptive and analytic epidemiologic knowledge, with an international perspective. While chapters are densely packed with information, they are well written, organized logically and systematically, and very readable. Graphs and other illustrations enhance the practicality and accessibility of the text. Prognostic aspects are discussed for some conditions, including osteoarthritis and gout, but a notable omission is the absence for other diseases, especially those with adverse prognostic implications such as systemic lupus erythematosus. If the book has a fault, it is the lack of systematic discussion on the current controversies and methodologic limitations of rheumatologic epidemiology. The population studies section provides an introductory level sketch but is incomplete, and these issues are addressed sporadically throughout the remainder of the text (e.g., ACR classification criteria sensitivity/specificity issues described in the rheumatoid arthritis chapter). For this reason, the book is more a comprehensive review than a tool to facilitate rigorous evaluation of the rheumatic disease epidemiology literature. This is a strong companion to current epidemiology and clinical rheumatology texts. It is suited for those seeking a quick reference, or an extensive review, of descriptive statistics and etiologic determinants, Recommended audiences include rheumatologists, medical trainees, and researchers in epidemiology and the basic sciences, including graduate students. Louise Murphy, Department of Public Health Sciences, University of Toronto, Toronto, Ontario, Canada. |